HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

Overview
Date Founded

1997

Headquarters

2711 Centerville Road,Suite 400,Wilmington, DE 19808

Type of Company

Public

Employees (Worldwide)

85

Industries

Commercial Scientific Research
IT Consulting & Services
Medical Support Services
Biotechnology

Company Description

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. Its customers include biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Executives & Employees

President, Chief Executive Officer & Director

Chief Financial Officer, Vice President-Finance & Administration

Senior Vice President & Chief Business Officer

Senior Vice President, Medical & Scientific Affairs

Vice President, Chief Legal Counsel & Secretary

Vice President-Regulatory Affairs & Quality System

Executive Director, US Business Development

Vice President, Operations

Vice President of North American Capital Sales-Htg Edgeseq Platform

Manager-Marketing & Communications

Subscribe now to see full list of current and former executives
Board of Directors

Managing Director & Founding Partner at BAR Capital Management LLC

President & Chief Executive Officer at bioTheranostics, Inc.

Former President & Chief Executive Officer at Vermillion, Inc.

President, Chief Executive Officer & Director at HTG Molecular Diagnostics, Inc.

Co-Founder at Solstice Capital LLC

Founder at TissueNetix, Inc.

Chief Executive Officer at Gensignia, Inc.

Subscribe now to see full list of current and former board members
Paths to HTG Molecular Diagnostics, Inc.
Potential Connections via
Relationship Science
You
HTG Molecular Diagnostics, Inc.
Owners & Shareholders
Details Hidden

Stonepine Capital Management focuses on long/short investments in the stocks of US small-cap companies in the healthcare technology sector

Details Hidden

Stonepine Capital Management focuses on long/short investments in the stocks of US small-cap companies in the healthcare technology sector

Subscribe now to see full details
Recent Transactions
Details Hidden

HTG Molecular Diagnostics, Inc. issued Common Stock

Details Hidden

HTG Molecular Diagnostics, Inc. issued Common Stock

Details Hidden

HTG Molecular Diagnostics, Inc. raised money in a private placement transaction

Subscribe now to see full list of recent transations
Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Subscribe now to see full details
Transaction Advisors
Escrow Agent

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Auditor

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Legal Advisor

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Subscribe now to see 7+ more transaction advisors
Managing Director

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Legal Advisor

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Associate

Advised onHTG Molecular Diagnostics, Inc. issued Common Stock

Subscribe now to see 13+ more transaction advisors
Advisors & Consultants
Subscribe now to see advisors & consultants for over 2.5 million organizations
Publicist

Vice President at Westwicke Partners LLC

Subscribe now to see advisors & consultants for over 2.5 million organizations
Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Merck KGaA engages in the manufacturing of pharmaceutical and chemical products. It operates through the following segments: Healthcare, Life Science, and Performance Materials. The Healthcare segment comprises the businesses with prescription and over-the-counter pharmaceuticals and biopharmaceuticals as well as allergy products. The Life Science segment offers solutions to research and analytical laboratories in the pharmaceutical/biotechnology industry or in academic institutions, and customers manufacturing large- and small-molecule drugs. The Performance Materials segment includes specialty chemicals, which are used in a variety of end products. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Subscribe now to see 2 more clients
Subscribe now to see clients for over 2.5 million organizations
Key Stats and Financials As of 2016
Market Capitalization
$46.9M
Total Enterprise Value
$15.9M
Earnings Per Share
$-3.66
Revenue
$5.13M
Net Profit
$-26M
EBITDA
$-22.9M
EBITDAMargin
-445.33%
Total Debt
$11.8M
Total Equity
$-5.59M
Enterprise Value Sales
3.1x
TEVNet Income
-0.61x
Debt TEV
0.74x
Three Year Compounded Annual Growth Rate Of Revenue
31.78%
Subscribe now to see full financial details
Investors
Details Hidden

Co-Founder at BioSypder Technologies, Inc.

Details Hidden

SR One focuses on investments in early-stage healthcare companies. The firm invests globally with a focus on North America and Europe. They invest at all stages of a company's development. SR One targets companies involved in drug discovery, drug development and tools that facilitate the discovery and development of new drugs. They are interested in companies with products that are in preclinical development through clinical proof-of-concept. SR One looks for investments that provide attractive financial returns and significant strategic value. The firm leads investments and works with other financial or strategic investors to syndicate deals. They are active investors and typically take board of directors or board observer seats. SR One is structured as an evergreen fund. They place approximately $25 million to $50 million each year, including follow-on investments in their portfolio companies. SR One invests between $500,000 and $5 million in each round of financing.

Details Hidden

Solstice Capital focuses on investments in seed- and early-stage companies in the areas of alternative energy, education, the environment, life sciences and information technology.Half of the firm's investments focus on the information technology sector. Their remaining activities focus on socially responsible investments in alternative energy, the environment, the life sciences and education. Solstice Capital looks for companies with experienced management teams. They also consider a company's products or services and their relationship to accessible markets. Solstice Capital seeks companies with technology, distribution arrangements or other factors that provide long-term sustainable competitive advantages. The firm also considers change factors such as technological or societal shifts that are creating the opportunity for a new entrant into the market.Initial investments range from $500,000 to $1 million. The firm participates in larger deals in conjunction with other venture capital firms, investors and angel groups. Most of the firm's investments are in companies located in the Northeastern and Southwestern regions of the US. The firm is a major investor in the Tucson market and in other areas of Arizona. They do consider investments throughout the US.

Subscribe now to see full details
Suppliers
Illumina, Inc. Medical Support Services | San Diego, California

Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function. It provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing services. The company customers include leading genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. Illumina was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Merck & Co., Inc. Medical Support Services | Kenilworth, New Jersey

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Invetech Pty Ltd. Other Manufacturing | Melbourne, VI

Invetech Pty Ltd. is a private company headquartered in Melbourne,, that provides design, engineering and contract manufacturing services for industrial, medical and consumer markets. The firm was founded by Alexander Gosling.

Subscribe now to see 1 more suppliers
Competitors
Abbott Laboratories Pharmaceuticals - Highland Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Chelmsford, MA

Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. The company operates its business through four segments: Analytical Technologies, Specialty Diagnostics, Life Sciences Solutions and Laboratory Products and Services. The Analytical Technologies segment is engaged in instruments, reagents, consumables, software and services that are used for applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products in order to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Life Sciences Solutions segment enable, simplify and accelerate a broad spectrum of biological research of genes, proteins and cells within academic and life science research, clinical research and commercial applications. The Laboratory Products and Services segment offers virtually everything needed for the laboratory. Thermo Fisher Scientific was founded in November, 2006 and is headquartered in Waltham, MA.

Genomic Health, Inc. Medical Support Services - Redwood City, CA

Genomic Health, a global health company founded in August of 2000 and located in Redwood City, California, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop clinically-validated molecular diagnostics which provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions. At Genomic Health, we developed and follow a highly specialized process that not only adheres rigorously to CAP (College of American Pathologists) standards and CLIA (Clinical Laboratory Improvement Amendments) regulations, but also incorporates numerous real-time quality checks and periodic proficiency testing designed to produce a high level of accuracy in information that we deliver to physicians and patients.